Evidence map›Paper›PMID 41866958›Full record

ArticleLupus2026

LUNELORD: A descriptive, prospective study on the demographics, disease characteristics and health-related quality of life of patients with LUpus NEphritis and long-term ORgan damage in rheumatology clinics in the Arabian Gulf.

Jamal Al-Saleh, Faisal Elbadawi, Rajaie Namas, Mohamed Elarabi, Samar Al-Emadi, Miral H Gharib, Khalid A Alnaqbi, Hiba Khogali, Humaid A Al Wahshi, Sadiq Abdul Baqi and 8 more

Abstract readMulticenter Study
In one paragraph

Article in Lupus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Jamal Al-SalehDepartment of Rheumatology, Dubai Health, Dubai Hospital, Dubai, United Arab Emirates.ORCID 0000-0002-7569-003X
Faisal ElbadawiDepartment of Rheumatology, Dubai Health, Dubai Hospital, Dubai, United Arab Emirates.ORCID 0000-0003-0282-4444
Rajaie NamasDivision of Rheumatology, Department of Internal Medicine, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.ORCID 0000-0003-0353-895X
Mohamed ElarabiDivision of Rheumatology, Department of Internal Medicine, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.ORCID 0000-0002-4412-8781
Samar Al-EmadiMedicine Department Rheumatology Section, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0001-7942-4831
Miral H GharibMedicine Department Rheumatology Section, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0001-9470-1569
Khalid A AlnaqbiRheumatology Division, Sheikh Tahnoon Medical City, SEHA / PureHealth, Al Ain, United Arab Emirates.ORCID 0000-0001-5875-4663
Hiba KhogaliRheumatology Division, Sheikh Tahnoon Medical City, SEHA / PureHealth, Al Ain, United Arab Emirates.ORCID 0009-0009-8666-0133
Humaid A Al WahshiDepartment of Rheumatology, The Royal Hospital, Muscat, Oman.ORCID 0009-0005-7980-9877
Sadiq Abdul BaqiDepartment of Rheumatology, The Royal Hospital, Muscat, Oman.
Amjad AlkadiRheumatology Unit, Ministry of Health, Alsabah Hospital, Kuwait, Kuwait.
Suad HannawiDepartment of Rheumatology, Al Kuwait Hospital Dubai, Dubai, United Arab Emirates.ORCID 0000-0002-5689-6710
Samah AllamDepartment of Rheumatology, Al Kuwait Hospital Dubai, Dubai, United Arab Emirates.
Reem Al-JayyousiCollege of Medicine, Mohamed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Mohamed HamoudaMedical Affairs Department, GSK Gulf, Dubai, United Arab Emirates.
Averyan VasylyevMedical Affairs Department, GSK Gulf, Dubai, United Arab Emirates.
Evelina ZimovetzMedical Affairs Department, GSK Gulf, Dubai, United Arab Emirates.
Munther KhamashtaMedical Affairs Department, GSK Gulf, Dubai, United Arab Emirates.ORCID 0000-0002-8927-6024

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundLupus nephritis (LN) is a major cause of morbidity and mortality among patients with systemic lupus erythematosus. However, there is a paucity of literature on the clinical characteristics and standard of care of patients in the Arabian Gulf. The LUNELORD study aimed to describe the demographics, clinical characteristics, treatment patterns and health-related quality of life (HRQoL) of patients with LN in the region.MethodsEligible adult patients with LN were enrolled from rheumatology centres in the UAE, Qatar, Oman and Kuwait and followed up for 12 months of routine care. Data were abstracted retrospectively from available medical charts up to 12 months prior to study enrolment, and prospectively from patients' medical charts after each follow-up visit. Patients completed the 36-Item Short Form Health Survey (SF-36) at the baseline and Month 12 visits to assess HRQoL.ResultsIncluded patients (

Indexed as

Lupus NephritisQuality of LifeAdultFemaleHumansImmunosuppressive AgentsKuwaitMaleMiddle AgedMiddle EastOmanProspective StudiesQatarImmunosuppressive AgentsArabian Gulflupus nephritisprospective studyquality of lifesystemic lupus erythematosus

Identifiers

PMID41866958
PMCPMC13129209

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.